BACKGROUND: Oligoclonal IgG bands in cerebrospinal fluid that are absent in serum indicate intrathecal IgG synthesis and are a sensitive marker of CNS inflammatory diseases, in particular multiple sclerosis. It may be of interest to determine whether these bands are predominantly IgGκ or IgGλ. METHODS: We have used Hevylite™ antibodies and developed a technique for detection of oligoclonal IgGκ and IgGλ bands by means of isoelectric focusing followed by immunoblotting. The same technique was used for oligoclonal free κ and free λ detection. Among several techniques tested, affinity immunoblotting appears to be the most sensitive; it can detect less than 1 ng of IgGκ or IgGλ paraprotein. We compared oligoclonal IgG profiles with those of oligoclonal IgGκ and IgGλ. There was good agreement concerning the presence or absence of intrathecal synthesis. We observed the ratios between oligoclonal IgGκ and IgGλ bands, and they did not always match the ratios between free κ and free λ bands. We were also able to detect antigen-specific CSF-restricted oligoclonal IgGκ and IgGλ bands in neuroborreliosis. It remains to be determined subsequently by a clinically-oriented prospective study, whether predominant IgGκ/IgGλ or free κ/free λ can be observed more frequently in particular diseases with oligoclonal IgG synthesis. DISCUSSION: Very sensitive detection of oligoclonal IgGκ and IgGλ bands in cerebrospinal fluid with Hevylite antibodies is feasible; detection of antigen-specific IgGκ or IgGλ is possible as well. In particular situations, e.g. when difficulties arise in distinguishing between oligoclonal and monoclonal pattern, the test may be of considerable clinical value.

Institute of Clinical Biochemistry University Hospital Ostrava 17 Listopadu 1790 708 52 Ostrava Poruba Czech Republic

Zobrazit více v PubMed

Andersson M, Alvarez-Cermeño J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Grønning M, Kier G, Lamers K, Link H, Magalhães A, Massaro AR, Öhman S, Reiber H, Rönnbäcks L, Schluep M, Schuller E, Sindic CJM, Thompson EJ, Trojano M, Wurster U. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994;57:897–902. doi: 10.1136/jnnp.57.8.897. PubMed DOI PMC

Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Öhman S, Racke MK, Sharief M, Sindic CJM, Sellebjerg F, Tourtellotte WW. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol. 2005;62:865–870. doi: 10.1001/archneur.62.6.865. PubMed DOI

Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness. J Neuroimmunol. 2006;180:17–28. doi: 10.1016/j.jneuroim.2006.07.006. PubMed DOI

Link H, Zettervall O. Multiple sclerosis: disturbed kappa:lambda chain ratio of immunoglobulin G in cerebrospinal fluid. Clin Exp Immunol. 1970;6:435–438. PubMed PMC

Roberts-Thomson PJ, Esiri MM, Young AC, Maclennan ICM. Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease. J Clin Path. 1976;29:1105–1115. doi: 10.1136/jcp.29.12.1105. PubMed DOI PMC

Eickhoff K, Heipertz R, Wikström J. Determination of k/l immunoglobulin light chain ratios in CSF from patients with multiple sclerosis and other neurological diseases. Acta Neurol Scand. 1978;57:385–395. PubMed

Eickhoff K. In: Neue Labormethoden für die Liquordiagnostik. Kleine T, editor. Stuttgart: Thieme; 1980. Messung und diagnostische Bedeutung des κ/λ-Quotienten; pp. 26–29.

Laurenzi MA, Link H. Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation. Ann Neurol. 1979;6:107–110. doi: 10.1002/ana.410060205. PubMed DOI

Kleine TO. Heterogeneous humoral immune responses in cerebrospinal fluid arising from inflammatory diseases of the human central nervous system. Detection of oligoclonal immunoglobulin bands after isoelectric focusing. Anal Chim Acta. 1999;393:83–93. doi: 10.1016/S0003-2670(99)00151-8. DOI

Jenkins MA, Cheng L, Ratnaike S. Multiple sclerosis: use of light-chain typing to assist diagnosis. Ann Clin Biochem. 2001;38:235–241. doi: 10.1258/0004563011900669. PubMed DOI

Araga S, Kagimoto H, Wada A, Funamoto K, Inoue K, Takahashi K. Kappa/lambda ratios in IgG, IgA and IgM of cerebrospinal fluid and of sera in patients with multiple sclerosis. Autoimmunity. 1989;5:133–137. doi: 10.3109/08916938909029151. PubMed DOI

Bradwell AR, Harding SJ, Fourrier NJ, Wallis GLF, Drayson MT, Carr-Smith HD, Mead GP. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin κ/λ ratios. Clin Chem. 2009;55(9):1646–1655. doi: 10.1373/clinchem.2009.123828. PubMed DOI

Bradwell AR. In: Serum free light chain analysis (plus Hevylite) 6. Bradwell AR, editor. Birmingham: The Binding Site Group Ltd; 2010. Analysis of immunoglobulin heavy chain/light chain pairs (Hevylite™) pp. 301–320.

Reiber H. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994;122:189–203. doi: 10.1016/0022-510X(94)90298-4. PubMed DOI

Reiber H, Kruse-Sauter L. for the German Society for CSF diagnostics and clinical neurochemistry, DGLN. Interpretation der Bandenmuster von oligoklonalem IgG in Liquor und Serum. http://www.uke.de/extern/dgln/

Knisley KA, Rodkey LS. Affinity immunoblotting. High resolution isoelectric focusing analysis of antibody clonotype distribution. J Immunol Methods. 1986;95:79–87. doi: 10.1016/0022-1759(86)90320-0. PubMed DOI

Kaiser R. Affinity immunoblotting: rapid and sensitive detection of oligoclonal IgG, IgA and IgM in unconcentrated CSF by agarose isoelectric focusing. J Neurol Sci. 1991;103:216–225. doi: 10.1016/0022-510X(91)90167-6. PubMed DOI

Sindic CJM, Laterre EC. Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study. J Neuroimmunol. 1991;33:63–72. doi: 10.1016/0165-5728(91)90035-6. PubMed DOI

Ikegaki N, Kennett RH. Glutaraldehyde fixation of the primary antibody-antigen complex on nitrocellulose paper increases the overall sensitivity of immunoblot assay. J Immunol Methods. 1989;124:205–210. doi: 10.1016/0022-1759(89)90354-2. PubMed DOI

Nováčková L, Zeman D. Detection of oligoclonal IgG bands in cerebrospinal fluid and serum: comparison between commercially available immunofixation method and home-made affinity immunoblotting method and evaluation of interobserver agreement. Klin Biochem Metabol. 2011;19:229–233.

Zettervall O, Link H. Electrophoretic distribution of kappa and lambda immunoglobulin light chain determinants in serum and cerebrospinal fluid in multiple sclerosis. Clin Exp Immunol. 1970;7:365–372. PubMed PMC

Gallo P, Visentini E, Tavolato B. Study of the IgG oligoclonal bands in cerebral spinal fluid in multiple sclerosis by electroimmunofixation. It J Neurol Sci. 1982;3:311–315. doi: 10.1007/BF02043579. PubMed DOI

Gofette S, Schluep M, Henry H, Duprez T, Sindic CJM. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004;75:308–310. doi: 10.1136/jnnp.2003.010710. PubMed DOI PMC

DeCarli C, Menegus MA, Rudick RA. Free light chains in multiple sclerosis and infections of the CNS. Neurology. 1987;37:1334–1338. PubMed

Fagnart OC, Sindic CJM, Laterre C. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J Neuroimmunol. 1988;19:119–132. doi: 10.1016/0165-5728(88)90041-0. PubMed DOI

Lolli F, Amaducci L. Measurement of free kappa immunoglobulin light chains in the cerebrospinal fluid by a competitive avidin-biotin ELISA. Clin Chim Acta. 1989;182:229–234. doi: 10.1016/0009-8981(89)90081-8. PubMed DOI

Totolyan NA, Gryazeva IV, Klimovich VB, Skoromets AA. [Content of free light chains of cerebrospinal fluid immunoglobulins and the importance of its estimation for differential diagnosis of multiple sclerosis] Zh Nevropatol Psikiatr Im S S Korsakova. 1994;94:49–53. PubMed

Fischer C, Arneth B, Koehler J, Lotz J, Lackner KJ. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clin Chem. 2004;50:1809–1813. doi: 10.1373/clinchem.2004.033977. PubMed DOI

Desplat-Jégo S, Feuillet L, Pelletier J, Bernard D, Ali Chérif A, Boucraut J. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry. J Clin Immunol. 2005;25:338–345. doi: 10.1007/s10875-005-5371-9. PubMed DOI

Presslauer S, Milosavljevic D, Brücke T, Bayer P, Hübl W. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J Neurol. 2008;255:1508–1514. doi: 10.1007/s00415-008-0954-z. PubMed DOI

Arneth B, Birklein F. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid. Acta Neurol Scand. 2009;119:39–44. doi: 10.1111/j.1600-0404.2008.01058.x. PubMed DOI

Kaplan B, Aizenbud BM, Golderman S, Yaskariev R, Sela BA. Free light chain monomers in the diagnosis of multiple sclerosis. J Neuroimmunol. 2010;229:263–271. doi: 10.1016/j.jneuroim.2010.09.002. PubMed DOI

Cotarlu D, Kaufman S, Golik A, Scharf S, Zaldman JL. Heavy- and free light-chain myeloma associated with peripheral polyneuropathy. Clin Chem. 1988;34/12:2594–2595. PubMed

Contini C, Fainardi E, Cultrera R, Seraceni S, Castellazzi M, Peyron F, Granieri E. Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis. J Neuroimmunol. 2000;108:221–226. doi: 10.1016/S0165-5728(00)00280-0. PubMed DOI

Van der Veeken J, Redegeld FA. Immunoglobulin free light chains in immune responses. Current Immunology Reviews. 2008;4:88–100. doi: 10.2174/157339508784325055. DOI

Nakano T, Matsui M, Inoue I, Awata T, Katayama S, Murakoshi T. Free immunoglobulin light chain: Its biology and implications in diseases. Clin Chim Acta. 2011;412:843–849. doi: 10.1016/j.cca.2011.03.007. PubMed DOI

Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases

Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting